Denali Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Denali Advisors LLC

  • $916 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 12, 2021
SELL
$574.03 - $680.96 $57,403 - $68,096
-100 Closed
0 $0
Q1 2021

Apr 26, 2021
BUY
$446.73 - $548.2 $44,673 - $54,820
100 New
100 $47,000
Q3 2020

Oct 16, 2020
SELL
$544.75 - $658.21 $54,475 - $65,821
-100 Closed
0 $0
Q2 2020

Jul 23, 2020
BUY
$493.32 - $643.92 $49,332 - $64,391
100 New
100 $62,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Denali Advisors LLC Portfolio

Follow Denali Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email